Oleg Nodelman, Director at Kindred Biosciences, Inc. (KIN), bought 100,000 shares at $9.56 ($956K) on 2014-09-29, disclosed to the SEC on 2014-09-30.
Open-market purchase of $956k KIN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.56 | 44,410 | $425K | 44.4% |
| 2 | $9.56 | 55,590 | $531K | 55.6% |
| Total | $9.56 avg | 100,000 | $956K | 100% |
| Filing → |
| ZYME | BUY | 2025-03-13 | $26.2M | — | Filing → |
| NUVB | BUY | 2023-09-21 | $6.7M | — | Filing → |
| ANAB | BUY | 2021-05-04 | $5.1M | — | Filing → |